Bangkok / Washington DC / Ulaanbaatar / Geneva / Riga / Harare / Atlanta / London / /
Continent
Americas / Africa / /
Country
Rwanda / Senegal / Niger / Mongolia / Burundi / Tajikistan / Cambodia / Equatorial Guinea / South Africa / Namibia / Kenya / Uganda / Malawi / Dominican Republic / Canada / Guinea-Bissau / Australia / Burkina Faso / Tanzania / Liberia / Botswana / United Kingdom / Philippines / Ethiopia / India / Cameroon / Zambia / Central African Republic / Haiti / Benin / Kingdom of Great Britain / Northern Ireland / Kyrgyzstan / Mozambique / Sweden / Gabon / Swaziland / Sudan / Zimbabwe / Congo / Guinea / Sri Lanka / Mali / Gambia / United States / Angola / Togo / Chad / Nigeria / Madagascar / Ghana / Papua New Guinea / Ukraine / Bhutan / Sierra Leone / /
Event
Environmental Issue / /
Facility
Global Drug Facility / /
IndustryTerm
web notifications / HIV prevention / treatment of second-stage disease / electronic systems / food / care for those with multidrug-resistant disease / social media / mass media / surveillance systems / laboratory diagnostic tools / health systems / drugsusceptibility testing technologies / Technology transfer / prevention of hepatitis / blood products / information technology systems / reinforced and operational health systems / disease surveillance systems / audio-visual products / regular services / programmatic management / HIV treatment / cholera prevention / /
MedicalCondition
fragile and human African trypanosomiasis / gonococcal infections / syphilis / HIV / reported cholera / hepatitis B / Secretariat CONTENTS Page Disease / HIV infections / dedicated hepatitis / Hepatitis / chronic form / drugresistant tuberculosis / drug-resistant tuberculosis / multidrug-resistant tuberculosis / Epidemic update / L. PREVENTION AND CONTROL OF SEXUALLY TRANSMITTED INFECTIONS / multidrugresistant tuberculosis / different diseases / hepatitis E / reported congenital syphilis / congenital syphilis / sexually transmitted infections / HIV/AIDS / HIV/AIDS epidemic / infection / viral hepatitis / paediatric HIV infections / I. Cholera / extensively drug-resistant tuberculosis / hepatitis A / TB / H. PREVENTION AND CONTROL OF MULTIDRUG-RESISTANT TUBERCULOSIS AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS / G. Viral hepatitis / hepatitis C / control cholera / both tuberculosis / African Trypanosomiasis / disease / J. CONTROL OF HUMAN AFRICAN TRYPANOSOMIASIS / multidrug-resistant disease / cholera / chronic hepatitis B / human African trypanosomiasis / tuberculosis / /
World Health Organization / Regional Office for Africa / Latin American Center for Perinatology / International Union against Sexually Transmitted Infections / African Union Commission / United Nations International Children's Emergency Fund / United Nations Children’s Fund East Asia and Pacific Regional Office / United Nations General Assembly / Regional Committee for Africa / Expert Committee on the Selection and Use of Essential Medicines / Health Protection Agency / civil society / European Centre for Disease Prevention and Control / Regional Committee for the Eastern Mediterranean / Division of STD Prevention / UNAIDS / Health Assembly / Regional Committee for Europe / Regional Committee for South-East Asia / EXECUTIVE BOARD / American Health Organization / Centers for Disease Control and Prevention / Europe Congress / World Bank / United Nations / World Health Assembly / Department of HIV / /
Position
Director-General / Major / microbiologist / /
Product
Consolidated / /
PublishedMedium
Oceania / /
Region
Oceania / Central Africa / sub-Saharan Africa / East Asia / Latin America / Caribbean / Asia-Pacific / /
Technology
information technology / Xpert MTB/RIF technology / drugsusceptibility testing technologies / pdf / /
Microsoft Word - B130_35Add2-en.doc